Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
3501
DELISTED
MAG Silver
MAG
| $463K | ﹤0.01% |
30,309
-218
| -0.7% | -$3.38K |
|
3502
PUT
Estee Lauder
EL
$31.6B
| $462K | ﹤0.01% |
7,000
-215,000
| -97% | -$15.6M |
|
3503
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
| $461K | ﹤0.01% |
2,279
+1,942
| +576% | +$415K |
|
3504
Vitamin Cottage Natural Grocers
NGVC
$646M
| $460K | ﹤0.01% |
11,451
-2,773
| -19% | -$116K |
|
3505
PUT
Southern Company
SO
$107B
| $460K | ﹤0.01% |
5,000
| – | – |
|
|
GRSD
3506
Grandstand Limited Ordinary Shares
GRSD
$67.3M
| $459K | ﹤0.01% |
36,398
-5,167
| -12% | -$72.7K |
|
3507
Lincoln Educational Services
LINC
$955M
| $458K | ﹤0.01% |
28,874
-10,396
| -26% | -$169K |
|
3508
Forum Energy Technologies
FET
$927M
| $456K | ﹤0.01% |
22,694
-7,157
| -24% | -$132K |
|
3509
Silvercrest Asset Management
SAMG
$79.5M
| $456K | ﹤0.01% |
27,894
-4,769
| -15% | -$84.8K |
|
3510
Unisys
UIS
$210M
| $455K | ﹤0.01% |
99,067
-63,040
| -39% | -$352K |
|
3511
Stoke Therapeutics
STOK
$2.02B
| $455K | ﹤0.01% |
68,361
-11,751
| -15% | -$110K |
|
3512
Clear Channel Outdoor Holdings
CCO
$1.18B
| $455K | ﹤0.01% |
409,548
-171,063
| -29% | -$226K |
|
3513
Cooper-Standard Automotive
CPS
$484M
| $454K | ﹤0.01% |
29,657
-4,560
| -13% | -$68.1K |
|
3514
Pacific Biosciences
PACB
$357M
| $454K | ﹤0.01% |
385,027
-1,275,032
| -77% | -$1.96M |
|
3515
Nkarta
NKTX
$165M
| $454K | ﹤0.01% |
246,863
-23,994
| -9% | -$49.2K |
|
3516
Nature's Sunshine
NATR
$269M
| $454K | ﹤0.01% |
36,190
-1,503
| -4% | -$21.1K |
|
3517
Franklin Covey
FC
$227M
| $453K | ﹤0.01% |
16,406
-18,486
| -53% | -$612K |
|
3518
PUT
Ultragenyx Pharmaceutical
RARE
$2.6B
| $453K | ﹤0.01% |
+12,500
| New | +$520K |
|
|
IBDQ
3519
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $452K | ﹤0.01% |
17,975
| – | – |
|
3520
SoundThinking
SSTI
$107M
| $452K | ﹤0.01% |
26,657
-5,820
| -18% | -$86.1K |
|
3521
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.38B
| $451K | ﹤0.01% |
18,632
| – | – |
|
|
EVBN
3522
DELISTED
Evans Bancorp Inc
EVBN
| $450K | ﹤0.01% |
11,551
-4,887
| -30% | -$205K |
|
3523
Inogen
INGN
$154M
| $449K | ﹤0.01% |
62,955
-2,871
| -4% | -$27.1K |
|
|
DHIL
3524
DELISTED
Diamond Hill
DHIL
| $448K | ﹤0.01% |
3,139
-1,928
| -38% | -$285K |
|
3525
Savara
SVRA
$1.08B
| $447K | ﹤0.01% |
161,483
-75,222
| -32% | -$208K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.